Cargando…

Effects of the glial modulator palmitoylethanolamide on chronic pain intensity and brain function

Background: Chronic neuropathic pain (NP) is a complex disease that results from damage or presumed damage to the somatosensory nervous system. Current treatment regimens are often ineffective. The major impediment in developing effective treatments is our limited understanding of the underlying mec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alshelh, Zeynab, Mills, Emily P, Kosanovic, Danny, Di Pietro, Flavia, Macey, Paul M, Vickers, E Russell, Henderson, Luke A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683964/ https://www.ncbi.nlm.nih.gov/pubmed/31447580 http://dx.doi.org/10.2147/JPR.S209657

Ejemplares similares

Altered Brainstem Pain-Modulation Circuitry Connectivity During Spontaneous Pain Intensity Fluctuations
por: Mills, Emily P, et al.
Publicado: (2020)

Altered regional brain T2 relaxation times in individuals with chronic orofacial neuropathic pain
por: Alshelh, Z., et al.
Publicado: (2018)

Disruption of default mode network dynamics in acute and chronic pain states
por: Alshelh, Z., et al.
Publicado: (2017)

Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy
por: Gabrielsson, Linda, et al.
Publicado: (2016)

Effect of palmitoylethanolamide on inflammatory and neuropathic pain in rats
por: Seol, Tai-Kyung, et al.
Publicado: (2017)

Effect of Expectation on Pain Processing: A Psychophysics and Functional MRI Analysis
por: Henderson, Luke A., et al.
Publicado: (2020)

Orofacial Pain Management: An Overview of the Potential Benefits of Palmitoylethanolamide and Other Natural Agents
por: Santonocito, Simona, et al.
Publicado: (2023)

Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain
por: Impellizzeri, Daniela, et al.
Publicado: (2014)

The Effect of Palmitoylethanolamide on Pain Intensity, Central and Peripheral Sensitization, and Pain Modulation in Healthy Volunteers—A Randomized, Double-Blinded, Placebo-Controlled Crossover Trial
por: Lang-Illievich, Kordula, et al.
Publicado: (2022)

ALIAmides Update: Palmitoylethanolamide and Its Formulations on Management of Peripheral Neuropathic Pain
por: D’Amico, Ramona, et al.
Publicado: (2020)

Brainstem Pain-Modulation Circuitry and Its Plasticity in Neuropathic Pain: Insights From Human Brain Imaging Investigations
por: Mills, Emily P., et al.
Publicado: (2021)

Delay of Morphine Tolerance by Palmitoylethanolamide
por: Di Cesare Mannelli, Lorenzo, et al.
Publicado: (2015)

Corrigendum: Brainstem Pain-Modulation Circuitry and Its Plasticity in Neuropathic Pain: Insights From Human Brain Imaging Investigations
por: Mills, Emily P., et al.
Publicado: (2021)

Erratum to: Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain
por: Impellizzeri, Daniela, et al.
Publicado: (2016)

The Basal Pharmacology of Palmitoylethanolamide
por: Rankin, Linda, et al.
Publicado: (2020)

Short-Term Efficacy of Ultramicronized Palmitoylethanolamide in Peripheral Neuropathic Pain
por: Cocito, Dario, et al.
Publicado: (2014)

Micronized Palmitoylethanolamide Reduces the Symptoms of Neuropathic Pain in Diabetic Patients
por: Schifilliti, Chiara, et al.
Publicado: (2014)

Synaptic Effects of Palmitoylethanolamide in Neurodegenerative Disorders
por: Assogna, Martina, et al.
Publicado: (2022)

Effect of ultramicronized-palmitoylethanolamide and co-micronized palmitoylethanolamide/polydatin on chronic pelvic pain and quality of life in endometriosis patients: An open-label pilot study
por: Stochino Loi, Emanuela, et al.
Publicado: (2019)

Comment on “Short-Term Efficacy of Ultramicronized Palmitoylethanolamide in Peripheral Neuropathic Pain”
por: Kriek, R.
Publicado: (2014)

Clinical applications of palmitoylethanolamide in pain management: protocol for a scoping review
por: Passavanti, Maria Beatrice, et al.
Publicado: (2019)

Chronic Pain in Dogs and Cats: Is There Place for Dietary Intervention with Micro-Palmitoylethanolamide?
por: della Rocca, Giorgia, et al.
Publicado: (2021)

Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine cream: modulation of nonneuronal cells
por: Keppel Hesselink, Jan M, et al.
Publicado: (2013)

The Protective Effects of Pre- and Post-Administration of Micronized Palmitoylethanolamide Formulation on Postoperative Pain in Rats
por: Siracusa, Rosalba, et al.
Publicado: (2020)

Possible Anandamide and Palmitoylethanolamide involvement in human stroke
por: Naccarato, Marcello, et al.
Publicado: (2010)

A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models
por: Britti, Domenico, et al.
Publicado: (2017)

Micronized Palmitoylethanolamide-Polydatin Reduces the Painful Symptomatology in Patients with Interstitial Cystitis/Bladder Pain Syndrome
por: Cervigni, M., et al.
Publicado: (2019)

Metabotropic Glutamate Receptor 5 and 8 Modulate the Ameliorative Effect of Ultramicronized Palmitoylethanolamide on Cognitive Decline Associated with Neuropathic Pain
por: Boccella, Serena, et al.
Publicado: (2019)

Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery
por: Puglia, Carmelo, et al.
Publicado: (2018)

Palmitoylethanolamide reduces granuloma-induced hyperalgesia by modulation of mast cell activation in rats
por: De Filippis, Daniele, et al.
Publicado: (2011)

A randomized controlled trial assessing the safety and efficacy of palmitoylethanolamide for treating diabetic-related peripheral neuropathic pain
por: Pickering, Emily, et al.
Publicado: (2022)

Combination of Rehabilitative Therapy with Ultramicronized Palmitoylethanolamide for Chronic Low Back Pain: An Observational Study
por: Scaturro, Dalila, et al.
Publicado: (2019)

Effect of Ultra-Micronized-Palmitoylethanolamide and Acetyl-l-Carnitine on Experimental Model of Inflammatory Pain
por: Ardizzone, Alessio, et al.
Publicado: (2021)

Altered resting activity patterns and connectivity in individuals with complex regional pain syndrome
por: Di Pietro, Flavia, et al.
Publicado: (2020)

Co-ultramicronized Palmitoylethanolamide/Luteolin Promotes the Maturation of Oligodendrocyte Precursor Cells
por: Barbierato, Massimo, et al.
Publicado: (2015)

Micronized Palmitoylethanolamide: A Post Hoc Analysis of a Controlled Study in Patients with Low Back Pain – Sciatica
por: Cruccu, Giorgio, et al.
Publicado: (2019)

Identification of a Widespread Palmitoylethanolamide Contamination in Standard Laboratory Glassware
por: Angelini, Roberto, et al.
Publicado: (2017)

Palmitoylethanolamide Modulation of Microglia Activation: Characterization of Mechanisms of Action and Implication for Its Neuroprotective Effects
por: D’Aloia, Alessia, et al.
Publicado: (2021)

Palmitoylethanolamide in the Treatment of Failed Back Surgery Syndrome
por: Paladini, Antonella, et al.
Publicado: (2017)

Palmitoylethanolamide: Prenatal Developmental Toxicity Study in Rats
por: Deshmukh, Narendra S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vo1dq205s1sdrdfmcoaooikr5t